Literature DB >> 31125392

Acquired Drug Resistance: Recognizing the Potential of Repurposed Drugs.

Jan-Willem C Alffenaar1,2, Vitali Sintchenko3,4,5, Ben J Marais6.   

Abstract

Year:  2019        PMID: 31125392     DOI: 10.1093/cid/ciz334

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  3 in total

1.  Integrating Pharmacokinetics and Pharmacodynamics in Operational Research to End Tuberculosis.

Authors:  Jan-Willem C Alffenaar; Tawanda Gumbo; Kelly E Dooley; Charles A Peloquin; Helen Mcilleron; Andre Zagorski; Daniela M Cirillo; Scott K Heysell; Denise Rossato Silva; Giovanni Battista Migliori
Journal:  Clin Infect Dis       Date:  2020-04-10       Impact factor: 9.079

2.  Cefdinir and β-Lactamase Inhibitor Independent Efficacy Against Mycobacterium tuberculosis.

Authors:  Shashikant Srivastava; Tania Thomas; Dave Howe; Lesibana Malinga; Prithvi Raj; Jan-Willem Alffenaar; Tawanda Gumbo
Journal:  Front Pharmacol       Date:  2021-06-07       Impact factor: 5.810

3.  Evaluation of Ceftriaxone Plus Avibactam in an Intracellular Hollow Fiber Model of Tuberculosis: Implications for the Treatment of Disseminated and Meningeal Tuberculosis in Children.

Authors:  Shashikant Srivastava; Johanna van Zyl; Kayle Cirrincione; Katherine Martin; Tania Thomas; Devyani Deshpande; Jan-William Alffenaar; James A Seddon; Tawanda Gumbo
Journal:  Pediatr Infect Dis J       Date:  2020-12       Impact factor: 3.806

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.